A Drug-Drug Interaction Study to Assess the Effect of Trametinib on the Pharmacokinetics of an Oral Contraceptive in Female Patients With Solid Tumors
Clinical trial NCT02705963 · COMPLETED
Trial details
- NCT number
- NCT02705963
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-20
- Primary completion
- 2019-08-29
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.